About Deucravacitinib
Class: | Janus kinase (JAK) inhibitor
Use: | Treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy
Adult dose: | 6 mg orally once daily
Pediatric dose: | Safety and efficacy not established in pediatric patients under 18 years of age
Side effects: | Common side effects include upper respiratory infections, headache, nausea, and fatigue
Contraindications: | Hypersensitivity to deucravacitinib or any component of the formulatio
Drug Class
Janus kinase (JAK) inhibitor
Uses & Indications
Treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy
Storage Requirements
Store at 20°C to 25°C (68°F to 77°F); protect from moisture and light
Manufacturer & Packaging
Manufacturer: Bristol Myers Squibb Company, U.S.A
Package Size
30's HDPE Bottle
Price & Supplier
Price in UAE: AED 5347.50
Dosage Information
Adult Dose
6 mg orally once daily
Pediatric Dose
Safety and efficacy not established in pediatric patients under 18 years of age
Side Effects
Common side effects include upper respiratory infections, headache, nausea, and fatigue
Contraindications & Precautions
Hypersensitivity to deucravacitinib or any component of the formulation; active serious infections
Important Warnings
Risk of serious infections, including tuberculosis; risk of malignancies; liver enzyme elevations; monitor for signs of thrombosis and cardiovascular events
Medical Disclaimer
This information is for educational purposes only and should not replace professional medical advice.
Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication.
The information presented here is specific to medicines available in UAE pharmacies and is regularly updated
to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.